Evaluation of the proper dosage of lapatinib and its safety in dogs

Evaluation of the proper dosage of lapatinib and its safety in dogs

Lapatinib is a low-molecular-weight agent targeting the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2). It is one of the antitumor agents used against advanced breast cancer in human. We intended to apply it against canine mammary gland tumors (cMGTs). To...

Full description

Bibliographic Details
Main Authors: Tanaka, Yuiko, Watanabe, Manabu, Saeki, Kohei, Ong, Siew Mei, Yoshitake, Ryohei, Imamura, Shohei, Nishimura, Ryohei, Sugano, Sumio, Nakagawa, Takayuki
Format: Article
Language:English
Published: Tokyo Metropolitan Institute of Medical Science 2020
Online Access:http://psasir.upm.edu.my/id/eprint/88878/
http://psasir.upm.edu.my/id/eprint/88878/1/DOG.pdf

Internet

http://psasir.upm.edu.my/id/eprint/88878/
http://psasir.upm.edu.my/id/eprint/88878/1/DOG.pdf

Similar Items